| ID | PMID | SEQUENCE | NAME | LENGTH | ACTIVITY |
| 3872 | 16722632 | YSA* | 9 | 3 | 6.2% inhibition at 10-6 |
| 3873 | 16722632 | YSA* | 9 | 3 | 6.4% inhibition at 10-5 |
| 3874 | 16722632 | YSA* | 9 | 3 | 8.2% inhibition at 10-4 |
| 3875 | 16722632 | YSA* | 9 | 3 | 21.2% inhibition at 10-3 |
| 3897 | 16722632 | YSA* | 10 | 3 | 8.5% inhibition at 10-6 |
| 3898 | 16722632 | YSA* | 10 | 3 | 4.9% inhibition at 10-5 |
| 3899 | 16722632 | YSA* | 10 | 3 | 1.9% inhibition at 10-4 |
| 3900 | 16722632 | YSA* | 10 | 3 | 16.2% inhibition at 10-3 |
| 3917 | 16722632 | YSA*G | 15 | 4 | 2.7% inhibition at 10-6M |
| 3918 | 16722632 | YSA*G | 15 | 4 | 2.0% inhibition at 10-5M |
| 3919 | 16722632 | YSA*G | 15 | 4 | 18.8% inhibition at 10-4M |
| 3920 | 16722632 | YSA*G | 15 | 4 | 26.7% inhibition at 10-3M |
| 3942 | 16722632 | YRA*G | 16 | 4 | 4.6% inhibition at 10-6M |
| 3943 | 16722632 | YRA*G | 16 | 4 | 4.9% inhibition at 10-5M |
| 3944 | 16722632 | YRA*G | 16 | 4 | 12.6% inhibition at 10-4M |
| 3945 | 16722632 | YRA*G | 16 | 4 | 26.4% inhibition at 10-3M |
| 3966 | 16722632 | YA*GFM | 17 | 5 | 1.0% inhibition at 10-6M |
| 3967 | 16722632 | YA*GFM | 17 | 5 | 10.1% inhibition at 10-5M |
| 3968 | 16722632 | YA*GFM | 17 | 5 | 16.8% inhibition at 10-4M |
| 3969 | 16722632 | YA*GFM | 17 | 5 | 36.1% inhibition at 10-3M |
| 3991 | 16722632 | YA*GFM | 18 | 5 | 13.7% inhibition at 10-6M |
| 3992 | 16722632 | YA*GFM | 18 | 5 | 25.8% inhibition at 10-5M |
| 3993 | 16722632 | YA*GFM | 18 | 5 | 34.7% inhibition at 10-4M |
| 3994 | 16722632 | YA*GFM | 18 | 5 | 44.5% inhibition at 10-3M |
| 4017 | 16722632 | YGGFMA* | 23 | 6 | 3.9% inhibition at 10-5M |
| 4018 | 16722632 | YGGFMA* | 23 | 6 | 45% inhibition at 10-3M |